Category Archives: News
Westin Immunogenicity Seminar September 27 2011, Tokyo, Japan
Westin Immunogenicity Seminar 2011 Tuesday, September 27, 2011 9:45 am – 6:10 pm Kiri Room The Westin Tokyo 1-4-1 Mita Meguro-ku, Tokyo 153-8580 Japan Speakers: Annie De Groot M.D. Director and Professor, Institute of Immunology and Informatics,University of Rhode Island … Continue reading
Any Prime-Boost Mix of Injected or Spray Flu Vaccine Shields Toddlers
Broadest Immune Response from Nasal Spray Vaccine, NIH-Funded Study Finds (The following is an excerpt from an article published by the National Institute of Allergy and Infectious Diseases on August 16, 2011. Featured in the article is Dr. Daniel Hoft, who … Continue reading
Posted in News
Leave a comment
Clinica Esperanza/Hope Clinic celebrates 1st Anniversary
According to EpiVax CEO De Groot, who is the volunteer Medical Director at Clinica Esperanza, improving access to care for uninsured patients will reduce the morbidity and mortality among the uninsured from preventable and treatable health problems. Dr. Peter Simon, medical director at the R.I. Department of Health, described the wide range of languages and cultures represented by volunteers, staff and patients as “a global health care experience at the reach of the local RIPTA bus line.”
Continue reading
Bringing hope and healthcare to the uninsured
“We were interested in providing culturally sensitive care to ununinsured patients in the patient’s own language,” says Dr. Annie De Groot, EpiVax CEO, who is also cofounder and volunteer Medical Director of the new clinic. Last year, the clinic’s first permanent location opened. Continue reading
Immunogenicity and Vaccine Talks 2011
Come hear the latest updates on better proteins and vaccines by design – See our list of speaking engagements and appearances here: Continue reading
Posted in Events, News
Tagged Biologics, biotech, Conference, Conferences, Immunogenicity, Tregitope, Tregitopes, Vaccine
Leave a comment
Expression of concern to our Japanese colleagues and friends
To our dear friends and colleagues in Japan We have been following the events that are unfolding in Japan with great concern. Our hearts go out to the victims of the great earthquake and tsunami of March 11, 2011. Please … Continue reading
Posted in Blog, News
Leave a comment
Agenda for Immunogenicity Determinants and Correlates Conference
Agenda for Immunogenicity Determinants and Correlates Conference – Valid as of March 05, 2011 Continue reading
Posted in Events, News
Tagged Biologics, biotech, Conference, iCubed, Immunogenicity, Tolerance, Tregitope, Tregitopes
1 Comment
4th Tregitope Update – Open Meeting May 11 2011
Tregitopes are small peptidic regulatory T-cell epitopes derived from human immunoglobulins that activate regulatory T cells (Tregs). Tregitope therapy has broad-reaching implications, offering new treatments for autoimmune diseases (e.g. type 1 juvenile diabetes, multiple sclerosis, rheumatoid arthritis, and lupus), allergies, and transplantation rejection. In previous meetings, the members of the Tregitope Collaborators team have demonstrated the immune suppressive capacity of Tregitopes. Ongoing research in the laboratories of the collaborators seeks to define the mechanism by which Tregitopes regulate immune responses and thereby accelerate the translation of this novel therapy to the clinic. Continue reading
Posted in Events, News
Tagged Biologics, Conference, Conferences, Tolerance, Tregitope, Tregitopes
2 Comments
Immunogenicity Determinants and Correlates: Registration Now Open
Immunogenicity: Determinants and Correlates is a non-commercial meeting, sponsored by the Institute for Immunology and Informatics and organized by individuals from a wide range of backgrounds including industry and academic settings. The current agenda, confirmed speakers, and the registration website are now posted for your review. Continue reading
Posted in Events, News
Tagged Biologics, Conference, Conferences, Immunogenicity, Tolerance, Tregitope, Tregitopes, TRIAD
1 Comment
Anti-Cancer Vaccine Progress at EpiVax
New study from Rhode Island Hospital identifies a potential vaccine to prevent gastritis, ulcer disease, gastric cancer HelicoVax vaccine targets H. pylori PROVIDENCE, R.I. – A new study led by researchers at Rhode Island Hospital in collaboration with the University … Continue reading
Posted in News
Leave a comment
